News | April 25, 2022
Global AYUSH meet ends with promise of Rs 9000 cr. in investment
Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal
Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal
Under the agreement, Porton Advanced will provide services to accelerate the development, production and registration of breakthrough cell therapies currently being developed by Sinorda Biomedicine
Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction
This is the first major brand refresh of CanSinoBIO since its inception in 2009
Partnership with Modality, award-winning GP super partnership
Heavy bleeding after giving birth is globally a leading cause of death in new mothers
If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe
All the capex is being met through internal accruals only
Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans
This recommendation is based on new data from two randomized controlled trials involving 3078 patients
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
